--The European Commission has closed deals with pharmaceutical companies Roche and Merck KGaA for the supply of experimental Covid-19 drugs in any European member state, Reuters reports, citing an unnamed source.
--The drugs that will be supplied are Roche's RoActemra, a treatment for rheumatoid arthritis, and Merck's Rebif, an anti-inflammatory drug, Reuters reports.
--The terms of the deal aren't known, Reuters reports.
Full story: https://reut.rs/3iJ72Xl
Write to Barcelona editors at barcelonaeditors@dowjones.com